glp-1 and dpp4 together receptor agonists DPP-4 inhibitors Pathway, Pharmacodynamics What is the future of

Acharya et al

Sun G, Mackey LV, Coy DH, Yu CY, Sun L

Joo HS, Suh JH, Lee HJ, Bang ES, Lee JM

Besides the acute phase gastrointestinal effects which may lead to up to 10% of people discontinuing the drugs, there are other potential GI side effects of obstruction, excessive loss of muscle mass, and potentially association with some eye disease adverse events

KLOW is a combination research blend of four peptides studied for overlapping regenerative and cytoprotective pathways: GHK-Cu (50mg), the copper tripeptide associated in published work with collagen and elastin synthesis, antioxidant activity and broad gene-expression modulation